Virtual Therapeutics Announces Results of Tender Offer to Acquire Akili Interactive

Virtual Therapeutics Acquisition of Akili, Inc.:

• Virtual Therapeutics has successfully completed a tender offer to acquire all outstanding shares of common stock of Akili, Inc.
• Approximately 88.2% of Akili's outstanding shares were validly tendered and not withdrawn.
• The merger between Alpha Merger Sub, Inc. and Akili is expected to occur on July 2, 2024.
• Following the merger, Akili will become a wholly owned subsidiary of Virtual Therapeutics.
• Akili's common stock ceased trading on Nasdaq and will be delisted.

About Akili and Virtual Therapeutics:

• Akili focuses on cognitive treatments through game-changing technologies.
• Virtual Therapeutics delivers scalable, accessible, and personalized mental health solutions using engaging experiences.
• Akili's products are delivered through action video game experiences.
• Virtual Therapeutics leverages game development expertise to provide mental health solutions.
• Both companies aim to bring new behavioral services to patients at scale.

Forward-looking Statements:

• The communication contains forward-looking statements regarding the acquisition.
• Actual events or results may differ from these forward-looking statements.
• Risks and uncertainties could impact the actual results of the acquisition.
• Virtual Therapeutics and Akili cannot guarantee future events or results.
• Investors are cautioned not to unduly rely on forward-looking statements.